Skip to content

Author

Yang Yang

We have 2 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Discovery of a novel BRD4 inhibitor for the treatment of acute myeloid leukemia.

Bromodomain-containing protein 4 (BRD4), an epigenetic regulatory reader, is closely related to the development of various cancers, so it has emerged as one of the most extensively investigated therapeutic targets for tumors. However, no BRD4 inhibitors have received clinical approval to date, underscoring the signific...

Yi-Sheng Li, Jing-Ying Liu, Jia Cheng et al. · 0 citations
Open access Jul 2026

An Integrated Transcriptional and Post-Transcriptional Regulatory Circuit Orchestrated by NUDT21 Maintains the Proliferation and Survival of Neuroblastoma.

This study identified NUDT21 as a critical driver of NB progression through both transcriptional and post-transcriptional mechanisms, laying the foundation for NUDT21-targeted NB therapies.

Yang Yang, Chunxia Shi, Jian-Wei Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.